Host and Pathogen

Host and Pathogen

The Max Planck Institute for Infection Biology focuses on understanding how microbes cause disease and how hosts respond to this challenge.

Our mission is to understand infections by viruses, bacteria, parasites, fungi and worms of two reasons: they present one of the most significant medical burdens on earth and the interaction between microbes and their host are an essential driver of evolution.

Science is Teamwork

Science is Teamwork

Our institute brings together scientists from various disciplines – in this way, we want to find answers to the fundamental questions of infection biology.

Hence the scale of our research spans through the atomic, molecular, cellular, tissular, organismal, clinical and finally social level.

In the Heart of Berlin

In the Heart of Berlin

The Max Planck Institute for Infection Biology is located at the historical Campus of the Charité Clinic in Berlin.

Since the year 2000 we are sharing the institute building with the Deutsches Rheuma-Forschungszentrum in the heart of Berlin - right between the main station and the government quarter.

News

Ernst Hellmut Vits Prize for Stefan H. E. Kaufmann
The Münster University Society honors the Max Planck scientist for his research achievements in the field of infection biology. Kaufmann studies the pathogens of threatening epidemics, develops vaccines and identifies biomarkers for better diagnosis and prognosis of diseases. At the award ceremony on November 8, the Emeritus Director of the Max Planck Institute (MPI) for Multidisciplinary Natural Sciences in Göttingen and the MPI for Infection Biology in Berlin received the 20,000 euro award.

Silvia Portugal receives the Bailey K. Ashford Medal
Lise Meitner Group Leader Silvia Portugal was awarded the Bailey K. Ashford Medal at the annual meeting of the American Society of Tropical Medicine & Hygiene (AMSTH) for her contribution to understanding the interactions between the malaria parasite Plasmodium falciparum and its host in a seasonally changing environment.

Tuberculosis vaccine passes safety test
The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed newborns
Go to Editor View